Based in Massachusetts and founded in 2010, Paragonix Technologies Inc., is a privately held medical device company innovating the Paragonix SherpaPak™, Paragonix SherpaLung™ and SherpaPerfusion™ Organ Transport Systems, a novel, single-use organ preservation device to improve donor organ quality. Paragonix has established a pipeline of donor organ transport devices that address the current donor organ shortage by maximizing donor organ utilization, improving donor organ quality and extending donor organ transport. Paragonix has developed organ preservation and transport devices for donor hearts, kidneys and lungs.
Paragonix supports the transplant community by establishing the new standard of care for donor organ preservation. Our mission is to expand today’s boundaries in the transport of donor organs.